PSA screening: the bottom line

Elhilali, Mostafa M.
March 2000
CMAJ: Canadian Medical Association Journal;3/21/2000, Vol. 162 Issue 6, p791
Academic Journal
Discusses the effectiveness of the prostate-specific antigen (PSA) test for prostate cancer. Belief that early diagnosis and treatment through PSA screening results in a dramatic decrease in deaths from prostate cancer; How prostate cancer is the second most frequent cause of cancer-related death among men.


Related Articles

  • PSA screening: a view from the front lines. Greiver, Michelle; Rosen, Noel // CMAJ: Canadian Medical Association Journal;3/21/2000, Vol. 162 Issue 6, p789 

    Focuses on the issue of prostate-specific antigen (PSA) screening for prostate cancer. Difficulty in advising patients about PSA screenings; How there is no evidence that screenings result in increased survival rates; Frequency of testing; Current practices.

  • New total PSA and free PSA criteria may reduce unnecessary prostate biopsies.  // Geriatrics;Jun2000, Vol. 55 Issue 6, p22 

    Discusses the results of the study conducted by researchers from Chicago, Illinois on the benefits of prostate cancer detection strategies. Benefits of using free PSA measurements; How the study was conducted; Details on the results of the study.

  • Speak Out. Jayson, Maury; Zipkin, Jeffrey W.; Jones, Gail Reede; Roddy, Timothy M. // Urology Times;Dec2009, Vol. 37 Issue 13, p27 

    The article presents several physicians' reactions regarding the American Urological Association's (AUA) recommendations that prostate-specific antigen (PSA) testing should start at age 40. Maury Jayson seconds the recommendation saying that he has seen prostate cancer cases at early ages....

  • TO TEST OR NOT TO TEST? Masters, Maria // Men's Health;Mar2010, Vol. 25 Issue 2, p128 

    The article discusses the prostate-specific antigen (PSA) test. Judd W. Moul, director of the Duke Prostate Center and a Men's Health advisor, says that PSA testing can undeniably save lives although many men risk being overdiagnosed and overtreated. A baseline PSA value is provided by the first...

  • Simulated Screening for Prostate Cancer: the Useful Model. Church, Timothy R. // JNCI: Journal of the National Cancer Institute;6/18/2003, Vol. 95 Issue 12, p838 

    Editorial. Discusses an effective model for a simulated screening of prostate cancer. Utility of cancer simulated screening by means of prostate-specific antigen; Adaptability of microsimulation for screening analysis (MISCAN); Number of estimated parameters in the MISCAN model.

  • What's the best approach for screening asymptomatic men for prostate cancer? Holten, Keith B.; Al-Abdulla, Sally // Journal of Family Practice;Dec2009, Vol. 58 Issue 12, pE4 

    The article presents the guidelines and vital approaches in conducting clinical screening for men who have never shown signs of prostate cancer. The U.S. Preventive Services Task Force (USPSTF) had issued a strategy that would counterbalance the increasing cases of prostate cancer in the U.S....

  • Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer. Bunting, Peter S.; Goel, Vivek; Williams, J. Ivan; Iscoe, Neill A. // CMAJ: Canadian Medical Association Journal;1/12/99, Vol. 160 Issue 1, p70 

    Presents a paper that reports on the first study in Canada to use physician records to assess the use of prostate-specific antigen (PSA) testing. Methods; Results; Conclusions.

  • Screening without evidence of efficacy. Law, Malcolm // BMJ: British Medical Journal (International Edition);2/7/2004, Vol. 328 Issue 7435, p301 

    Reports on the use of medical screening to diagnose diseases. Use of prostate specific antigens in the detection of prostate cancer; Problems with medical screenings.

  • Prostate Screenings May Do More Harm Than Good.  // Jet;8/25/2008, Vol. 114 Issue 7, p18 

    The author reports that the U.S. Preventative Services Task Force has recommended that men over the age of 75 do not get screened for prostate cancer. According to the article, the prostate-specific antigen (PSA) screening can be more harmful than helpful to men over the age of 75....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics